• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 9/25/24: Coverage from LogiPharma USA 2024, The Joys of Talking to ChatGPT & more

News
Article

The latest news for pharma industry insiders.

LogiPharma USA 2024: DSCSA Compliance Preparation

In an interview with Pharma Commerce Editor Nicholas Saraceno, Mark Karhoff, supply chain & DSCSA consultant, National Association of Boards of Pharmacy, discusses insurances to the upcoming DSCSA deadline.

Role of Biosimilars in Gastrointestinal Diseases

A gastroenterologist discusses the role of biosimilars in her clinical practice.

The Joys of Talking to ChatGPT

Among the ways I find it useful: It helps me cure writer’s block, prepare for meetings in the car and sightsee. Oh, and hang curtains.

MedImpact Launches Holistic, Personalized Condition Management Solution

MedImpact unveiled MedEmpower FuelTM, a personalized, integrated, whole health approach to nutrition, weight loss, and chronic condition management. Incorporating a consumer app, coaching, and advanced clinical support, MedEmpower Fuel offers a tiered approach to engaging members with the greatest health challenges and risks to improve care and control costs.

Miranda Schmalfuhs on LinkedIn

Check out this first part of my talk with Jonathan Scheinberg! More to come through this week and early next!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs